Efficacy and Safety of High Absorption Pad in Split-thickness Skin Graft Donor Site Wound
NCT ID: NCT04299126
Last Updated: 2020-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
24 participants
INTERVENTIONAL
2020-03-05
2021-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites
NCT02643680
Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh
NCT01769144
Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing
NCT02091076
Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment
NCT01539980
Clinical Efficacy of Silk Sericin Dressing With Collagen for Split-thickness Skin Graft Donor Site Treatment
NCT04743375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high absorption pad for blood and pus
High absorption pad for blood and pus with natural antimicrobial agent composes of sericin and chitosan. It will be covered on half of split-thickness skin graft donor site wound until the wound has healed.
high absorption pad for blood and pus
High absorption pad for blood and pus will be covered on half of split-thickness skin graft donor site wound until the wound has healed.
commercial wound dressing
Commercial wound dressing is gauze dressing impregnated with paraffin, containing 0.5% chlorhexidine acetate (Bactigras). It will be covered on half of split-thickness skin graft donor site wound until the wound has healed.
commercial wound dressing
Commercial wound dressing will be covered on half of split-thickness skin graft donor site wound until the wound has healed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high absorption pad for blood and pus
High absorption pad for blood and pus will be covered on half of split-thickness skin graft donor site wound until the wound has healed.
commercial wound dressing
Commercial wound dressing will be covered on half of split-thickness skin graft donor site wound until the wound has healed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-60 years
* Can read and write
* Can follow the study protocol
* Available on appointment date
Exclusion Criteria
* Chronic skin diseases
* Immune deficiency
* Allergic to cellulose, chitosan, sericin, and chlorhexidine
* Psychotic disorders
* Pregnancy or breast feeding
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pornanong Aramwit, Pharm.D., Ph.D
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
625/62
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.